Fluorination of PVC medical devices to prevent plasticizers migration.


Journal

International journal of pharmaceutics
ISSN: 1873-3476
Titre abrégé: Int J Pharm
Pays: Netherlands
ID NLM: 7804127

Informations de publication

Date de publication:
25 Aug 2023
Historique:
received: 03 04 2023
revised: 13 07 2023
accepted: 17 07 2023
medline: 21 8 2023
pubmed: 21 7 2023
entrez: 20 7 2023
Statut: ppublish

Résumé

Medical devices (MD) are often made of plasticized polyvinylchloride (PVC). However, plasticizers may leach out into infused solutions and expose the patients to a toxic risk. The aim of the present work is to fluorinate plasticized PVC tubular MDs to create a barrier layer on their internal surface, and to study the impact of such a chemical treatment on the migration of the plasticizers. Following fluorination by pure molecular fluorine, the physico-chemical characterization of these modified MDs was carried out using various spectroscopic and microscopic techniques or tensile tests, evidencing the formation of covalent C-F bonds on the surface of the treated samples without modification of their mechanical and optical properties. The migration of plasticizers from fluorinated MDs was assessed using gas chromatography coupled with mass spectrometry and was found considerably decreased in comparison with the pristine MDs. After 24 h, the amount of tri-octyltrimellitate plasticizer (TOTM) detected in migrates from fluorinated MDs was even lower than the limit of quantification. Complementary cytotoxicity assays were performed according to the ISO EN 10993-5 standard, showing that the new fluorinated material does not cause a cytotoxic effect on L929 cells.

Identifiants

pubmed: 37473975
pii: S0378-5173(23)00674-9
doi: 10.1016/j.ijpharm.2023.123254
pii:
doi:

Substances chimiques

Plasticizers 0
Polyvinyl Chloride 9002-86-2
Diethylhexyl Phthalate C42K0PH13C

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

123254

Informations de copyright

Copyright © 2023 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Imen Dhifallah (I)

Institut de Chimie de Clermont-Ferrand, Université Clermont Auvergne, 63178 Aubière, France. Electronic address: dhifallah_imen@live.fr.

Daniel Claves (D)

Institut de Chimie de Clermont-Ferrand, Université Clermont Auvergne, 63178 Aubière, France.

Nicolas Batisse (N)

Institut de Chimie de Clermont-Ferrand, Université Clermont Auvergne, 63178 Aubière, France.

Régis Cueff (R)

Institut de Chimie de Clermont-Ferrand, Université Clermont Auvergne, 63178 Aubière, France.

Anne-Francoise Sapin (AF)

Université Clermont Auvergne, CHU Clermont-Ferrand, CNRS, SIGMA Clermont, ICCF, 63000 Clermont-Ferrand, France.

Yassine Bouattour (Y)

Université Clermont Auvergne, CHU Clermont-Ferrand, CNRS, SIGMA Clermont, ICCF, 63000 Clermont-Ferrand, France.

Elodie Petit (E)

Institut de Chimie de Clermont-Ferrand, Université Clermont Auvergne, 63178 Aubière, France.

Marc Dubois (M)

Institut de Chimie de Clermont-Ferrand, Université Clermont Auvergne, 63178 Aubière, France.

Valérie Sautou (V)

Université Clermont Auvergne, CHU Clermont-Ferrand, CNRS, SIGMA Clermont, ICCF, 63000 Clermont-Ferrand, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH